DEVELOPMENT OF A NINTEDANIB TECHNOSPHERE POWDER FOR TARGETED LUNG DELIVERY IN THE TREATMENT OF IDIOPATHIC PULMONARY FIBROSIS

被引：0

作者：

Hofmann, Thomas ^{[1
]}

Grant, Marshall ^{[1
]}

Ufer, Stefan ^{[2
]}

Castagna, Michael ^{[1
]}

Freeman, John ^{[1
]}

机构：

[1] Mannkind, Danbury, CT USA

[2] Swabian, Raleigh, NC USA

来源：

JOURNAL OF AEROSOL MEDICINE AND PULMONARY DRUG DELIVERY | 2023年 / 36卷 / 06期

关键词：

D O I：

暂无

中图分类号：

R56 [呼吸系及胸部疾病];

学科分类号：

摘要：

E. 16

引用

页码：A16 / A16

页数：1

共 50 条

[41] Reducing lung function decline in patients with idiopathic pulmonary fibrosis: potential of nintedanib [J].

Woodcock, Hannah V. ;

Molyneaux, Philip L. ;

Maher, Toby M. .

DRUG DESIGN DEVELOPMENT AND THERAPY, 2013, 7 :503-510

[42] Modulation Of Normal And Idiopathic Pulmonary Fibrosis Lung Fibroblast Motility And Invasion By Nintedanib [J].

Habiel, D. ;

Espindola, M. ;

Narayanan, R. ;

Jones, I. ;

Coelho, A. ;

Wollin, L. ;

Hogaboam, C. M. .

AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2017, 195

[43] Nintedanib Attenuates Motility Of Lung Fibroblasts From Patients With Idiopathic Pulmonary Fibrosis [J].

Wollin, L. ;

Ostermann, A. ;

Wex, E. ;

Herrmann, F. E. ;

Doods, H. .

AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2014, 189

[44] IDIOPATHIC PULMONARY FIBROSIS Underestimating treatment benefit of lung transplantation for idiopathic pulmonary fibrosis [J].

Riddell, P. ;

Eaton, D. ;

Miller, A. B. ;

Wells, A. U. ;

Egan, J. J. .

BMJ-BRITISH MEDICAL JOURNAL, 2014, 348

[45] Systemic delivery of nintedanib using PLGA-based discoidal polymeric particles for idiopathic pulmonary fibrosis treatment [J].

Park, S. ;

Park, J. Y. ;

Nahm, J. H. ;

Kim, G. ;

Cho, Y. L. ;

Kang, W. J. ;

Key, J. .

MATERIALS TODAY CHEMISTRY, 2022, 26

[46] Systemic delivery of nintedanib using PLGA-based discoidal polymeric particles for idiopathic pulmonary fibrosis treatment [J].

Park, S. ;

Park, J.Y. ;

Nahm, J.H. ;

Kim, G. ;

Cho, Y.L. ;

Kang, W.J. ;

Key, J. .

Materials Today Chemistry, 2022, 26

[47] The development of a measure to better understand patient experiences with pirfenidone and nintedanib for the treatment of idiopathic pulmonary fibrosis (IPF) [J].

Wijsenbeek-Lourens, Marlies S. ;

Kimman, Merel L. ;

Rotteveel, Adrienne ;

van Jaarsveld, Xana ;

Weinreich, Stephanie S. ;

Mostard, Remy ;

Dirksen, Carmen D. .

EUROPEAN RESPIRATORY JOURNAL, 2016, 48

[48] Pulmonary Hypertension Exacerbated by Nintedanib Administration for Idiopathic Pulmonary Fibrosis [J].

Shimomura, Iwao ;

Abe, Mitsuhiro ;

Li, Yu ;

Tsushima, Kenji ;

Sakao, Seiichiro ;

Tanabe, Nobuhiro ;

Ikusaka, Masatomi ;

Tatsumi, Koichiro .

INTERNAL MEDICINE, 2019, 58 (07) :965-968

[49] Nintedanib - efficacy, safety and practical aspects of treatment for patients with idiopathic pulmonary fibrosis [J].

Martusewicz-Boros, Magdalena ;

Gorska, Katarzyna .

ADVANCES IN RESPIRATORY MEDICINE, 2020, 88 (06) :599-607

[50] A new Humanized Mouse Model for Idiopathic Pulmonary Fibrosis and Effects of Nintedanib Treatment [J].

Prasse, Antje ;

Jaeger, Benedikt ;

Plappert, Linda ;

Kraus, Kim ;

Wollin, Lutz .

EUROPEAN RESPIRATORY JOURNAL, 2018, 52

← 1 2 3 4 5 →